Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 4 (April)

1. Toward convergence in the medication treatment of bipolar disorder and schizophrenia.
   Harv Rev Psychiatry, 13(1): 28-42. [Abstract] [Full-text]
2. Utilization of emergency center services by older adults with a psychiatric diagnosis.
   Aging Ment Health, 9(2): 172-6. [Abstract] [Full-text]
3. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia.
   Int J Neuropsychopharmacol. [Abstract] [Full-text]
4. Affect-modulated startle in adults with childhood-onset depression: relations to bipolar course and number of lifetime depressive episodes.
   Psychiatry Res, 134(1): 11-25. [Abstract] [Full-text]
5. Health service use among persons with comorbid bipolar and substance use disorders.
   Psychiatr Serv, 56(4): 475-80. [Abstract] [Full-text]
6. Microarray analysis of rat brain gene expression after chronic administration of sodium valproate.
   Brain Res Bull, 65(4): 331-8. [Abstract] [Full-text]
7. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population.
   Clin Ther, 27(2): 263-72. [Abstract] [Full-text]
8. Increased risk of affective disorder following hospitalisation with hyperthyroidism - a register-based study.
   Eur J Endocrinol, 152(4): 535-43. [Abstract] [Full-text]
9. Nogo CAA 3'UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder.
   Schizophr Res, 75(1): 5-9. [Abstract] [Full-text]
10. Lamotrigine for the treatment of bipolar spectrum disorder: a chart review.
    J Affect Disord, 86(1): 69-73. [Abstract] [Full-text]
11. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.
    J Affect Disord, 86(1): 61-7. [Abstract] [Full-text]
12. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span.
    J Affect Disord, 86(1): 47-60. [Abstract] [Full-text]
13. Seasonality in a community sample of bipolar, unipolar and control subjects.
    J Affect Disord, 86(1): 19-25. [Abstract] [Full-text]
14. Do social anxiety disorder patients belong to a bipolar spectrum subgroup?
    J Affect Disord, 86(1): 11-8. [Abstract] [Full-text]
15. Treatment guidelines for bipolar disorder: a critical review.
    J Affect Disord, 86(1): 1-10. [Abstract] [Full-text]
16. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses.
    Biol Psychiatry, 57(7): 733-42. [Abstract] [Full-text]
17. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
    Biol Psychiatry, 57(7): 716-25. [Abstract] [Full-text]
18. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
    Biol Psychiatry, 57(7): 711-5. [Abstract] [Full-text]
19. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1).
    Biol Psychiatry, 57(7): 696-701. [Abstract] [Full-text]
20. Assaultive trauma and illness course in psychotic bipolar disorder: findings from the Suffolk county mental health project.
    Acta Psychiatr Scand, 111(5): 380-3. [Abstract] [Full-text]
21. Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.
    Psychopharmacology (Berl), 179(2): 447-51. [Abstract] [Full-text]
22. Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test.
    Neurosci Lett, 379(2): 122-6. [Abstract] [Full-text]
23. Recent findings on the genetic basis of bipolar disorder.
    Psychiatr Clin North Am, 28(2): 481-98, ix. [Abstract] [Full-text]
24. Hypothalamic-pituitary-adrenal axis and bipolar disorder.
    Psychiatr Clin North Am, 28(2): 469-80. [Abstract] [Full-text]
25. Magnetic resonance findings in bipolar disorder.
    Psychiatr Clin North Am, 28(2): 443-67. [Abstract] [Full-text]
26. Cognition in bipolar disorder.
    Psychiatr Clin North Am, 28(2): 427-41. [Abstract] [Full-text]
27. Bipolar disorder and substance abuse.
    Psychiatr Clin North Am, 28(2): 415-25. [Abstract] [Full-text]
28. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Psychiatr Clin North Am, 28(2): 399-414. [Abstract] [Full-text]
29. Pharmacotherapy of children and adolescents with bipolar disorder.
    Psychiatr Clin North Am, 28(2): 385-97. [Abstract] [Full-text]
30. Psychosocial treatments for bipolar disorders.
    Psychiatr Clin North Am, 28(2): 371-84. [Abstract] [Full-text]
31. Treatment of bipolar depression.
    Psychiatr Clin North Am, 28(2): 349-70, vii. [Abstract] [Full-text]
32. Atypical antipsychotics for bipolar disorder.
    Psychiatr Clin North Am, 28(2): 325-47. [Abstract] [Full-text]
33. Anticonvulsants in bipolar disorder.
    Psychiatr Clin North Am, 28(2): 301-23. [Abstract] [Full-text]
34. Coping with depression and vulnerability to mania: a factor analytic study of the Nolen-Hoeksema (1991) Response Styles Questionnaire.
    Br J Clin Psychol, 44: 99-112. [Abstract] [Full-text]
35. Are measures of hypomanic personality, impulsive nonconformity and rigidity predictors of bipolar symptoms?
    Br J Clin Psychol, 44: 15-27. [Abstract] [Full-text]
36. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan.
    BMC Med Genet, 6: 14. [Abstract] [Full-text]
37. Caregiver-coping in bipolar disorder and schizophrenia A re-examination.
    Soc Psychiatry Psychiatr Epidemiol, 40(4): 329-36. [Abstract] [Full-text]
38. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
    Brain Res Bull, 65(5): 397-403. [Abstract] [Full-text]
39. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
40. Valproate in bipolar disorder: 2000 onwards.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
41. Lithium - a continuing story in the treatment of bipolar disorder.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
42. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
    Mol Pharmacol, 67(5): 1426-33. [Abstract] [Full-text]
43. Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons.
    Proc Natl Acad Sci U S A, 102(16): 5850-5. [Abstract] [Full-text]
44. A pilot study of standardized treatment in geriatric bipolar disorder.
    Am J Geriatr Psychiatry, 13(4): 319-23. [Abstract] [Full-text]
45. Maintenance treatment outcomes in older patients with bipolar I disorder.
    Am J Geriatr Psychiatry, 13(4): 305-11. [Abstract] [Full-text]
46. New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice.
    Am J Geriatr Psychiatry, 13(4): 299-304. [Abstract] [Full-text]
47. Differences in clinical features and mental health service use in bipolar disorder across the lifespan.
    Am J Geriatr Psychiatry, 13(4): 290-8. [Abstract] [Full-text]
48. New-onset bipolar disorder in later life.
    Am J Geriatr Psychiatry, 13(4): 282-9. [Abstract] [Full-text]
49. Electroconvulsive therapy: a selected review.
    Am J Geriatr Psychiatry, 13(4): 268-81. [Abstract] [Full-text]
50. Review of the use of Topiramate for treatment of psychiatric disorders.
    Ann Gen Psychiatry, 4(1): 5. [Abstract] [Full-text]
51. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.
    Ann Gen Psychiatry, 4(1): 1. [Abstract] [Full-text]
52. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
    Eur J Neurosci, 21(6): 1712-8. [Abstract] [Full-text]
53. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet, 135(1): 94-101. [Abstract] [Full-text]
54. Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders.
    Am J Med Genet B Neuropsychiatr Genet, 135(1): 85-93. [Abstract] [Full-text]
55. Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 135(1): 47-9. [Abstract] [Full-text]
56. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region.
    Am J Med Genet B Neuropsychiatr Genet, 135(1): 50-8. [Abstract] [Full-text]
57. Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers.
    Int J Neuropsychopharmacol, 8(2): 255-9. [Abstract] [Full-text]
58. The metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
    Int J Neuropsychopharmacol, 8(2): 153-6. [Abstract] [Full-text]
59. Rapid cycling bipolar disorder: biology and pathogenesis.
    Int J Neuropsychopharmacol, 8(2): 281-92. [Abstract] [Full-text]
60. Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders.
    Int J Neuropsychopharmacol, 8(2): 235-44. [Abstract] [Full-text]
61. Vitamin D receptor variants in 192 patients with schizophrenia and other psychiatric diseases.
    Neurosci Lett, 380(1): 37-41. [Abstract] [Full-text]
62. Risperidone for bipolar disorders.
    Expert Rev Neurother, 5(2): 177-87. [Abstract] [Full-text]
63. Divalproex sodium in the treatment of pediatric psychiatric disorders.
    Expert Rev Neurother, 5(2): 165-76. [Abstract] [Full-text]
64. 5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens.
    Cancer Chemother Pharmacol, 55(6): 541-51. [Abstract] [Full-text]
65. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
    Acta Crystallogr D Biol Crystallogr, 61: 545-55. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.